{"id":"W3202234535","doi":"10.1056/nejmoa2105290","title":"Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine","year":2021,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":683,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Institute of Allergy and Infectious Diseases; Biomedical Advanced Research and Development Authority; National Center for Advancing Translational Sciences; Johns Hopkins Bloomberg School of Public Health; Irving Medical Center, Columbia University; University of California, San Diego; AstraZeneca; York University; Emory University; Universidad de Chile; University of Rochester; University of Vermont; University of Washington; Johns Hopkins University; U.S. Department of Health and Human Services; National Institutes of Health; Children's Mercy Hospital","keywords":"Phase (matter); Vaccination; Immune system; Immunogenicity; Disease","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002578702,0.0009452713,0.001264891,0.0002983391,0.0003815348,0.0006470522,0.0007036552,0.0009226658,0.00494178],"category_scores_gemma":[0.00176009,0.0003826368,0.0009250737,0.0002498892,0.0006338439,0.0005263273,0.0003737142,0.001439216,0.0005252202],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007960078,"about_ca_system_score_gemma":0.001602907,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008279408,"about_ca_topic_score_gemma":0.001179607,"domain_scores_codex":[0.9990326,0.0005882378,0.00005655962,0.0001106704,0.0001117963,0.0001001445],"domain_scores_gemma":[0.9989001,0.0002166996,0.0004173761,0.00008834769,0.0001492311,0.000228319],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8772971,0.03082739,0.006752596,0.001201634,0.00137904,0.0000875343,0.0002063171,0.001166673,0.03349408,0.0001855202,0.002346788,0.04505535],"study_design_scores_gemma":[0.5930168,0.3804485,0.01680127,0.00007248586,0.0005999643,0.0001157539,0.0000461789,0.0005767171,0.005304287,0.0002037652,0.002789323,0.00002493929],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9884405,0.001444364,0.0008313867,0.0002380791,0.00007963054,0.005844322,0.001928503,0.00006306807,0.001130146],"genre_scores_gemma":[0.9826056,0.0009946618,0.002119235,0.0005895565,0.0001494662,0.009502876,0.002270923,0.00002292123,0.001744839],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00494178,"threshold_uncertainty_score":0.01653194,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05032354525739646,"score_gpt":0.3948834473271394,"score_spread":0.344559902069743,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}